Literature DB >> 1730175

Acquired benign and "borderline" vascular lesions.

S J Hunt1, D J Santa Cruz.   

Abstract

In recent years, the classification of vascular lesions has been expanded and modified with the addition of several newly described entities, the redefinition of others, the recognition of lesions of borderline biologic behavior, and the need to avoid misdiagnosis with early Kaposi's sarcoma. This review clarifies the nomenclature, updates information on previously known lesions, and summarizes data on several recently discovered, lesser-known entities such as glomeruloid hemangioma, microvenular hemangioma, and multinucleate cell angiohistiocytoma. Clinicopathologic features and differential diagnosis are emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1730175

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Atypical angioma serpiginosum.

Authors:  Ju-Hsin Chen; Kuo-Hsien Wang; Chung-Hong Hu; Jainn-Shiun Chiu
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

2.  Spindle cell hemangioendothelioma of the spinal cord.

Authors:  Z Mahdavi; M R Grafe; R Ostrup; P Kormanik; M C Chamberlain
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

3.  Late-onset Segmental Angioma Serpiginosum.

Authors:  Sushil S Savant; Anupam Das; Piyush Kumar; Shahid Hassan
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

4.  Angioma serpiginosum: Two cases in children and review of literature.

Authors:  Elena Sammarco; Orsola Ametrano; Maria Elena Errico; Giuseppe Ruocco; Delfina Bifano; Filomena Barbato; Mario Diplomatico
Journal:  Dermatol Reports       Date:  2022-03-14

5.  Angioma Serpiginosum in a Patchy and Blaschkoid Distribution: A Rare Condition with an Unconventional Presentation.

Authors:  Karan Sancheti; Anupam Das; Indrashis Podder; Ramesh Chandra Gharami
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.